权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

2/2 Rare Genetic Variation and Risk for Obsessive Compulsive Disorder

2/2 罕见的基因变异和强迫症的风险

基本信息

批准号：
10516725
负责人：
James Joseph Crowley
金额：
$ 19.44万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-12-15 至 2025-10-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10516725
关键词：
Adolescent Affect Area Attention deficit hyperactivity disorder Awareness Biological Biology Bipolar Disorder Child Chronic Clinical Code Collaborations Collection Complex Copy Number Polymorphism Country DNA DNA Resequencing Data Data Set Detection Development Disease Environmental Risk Factor Etiology Functional disorder Gene Dosage Gene Expression Genes Genetic Genetic Risk Genetic Variation Genome Genotype Gilles de la Tourette syndrome Goals Human Individual Inherited Intellectual functioning disability Knowledge Learning Mental disorders Methods Molecular Molecular Target Neurodevelopmental Disorder Norway Nucleotides Obsessive compulsive behavior Obsessive-Compulsive Disorder Outcome Parents Pathway interactions Peptide Sequence Determination Play Population Prevention strategy Price Proteins Psychiatric Diagnosis Psychiatrist Public Health Publishing Research Risk Role Sampling Schizophrenia Site Specificity Sweden System Tic disorder Variant analytical method autism spectrum disorder case control cell type comorbidity disorder risk exome exome sequencing follow-up gene discovery genetic architecture genetic risk factor genome-wide improved insertion/deletion mutation method development neuropsychiatry new therapeutic target non-genetic novel phenotypic data power analysis psychiatric comorbidity psychiatric genomics risk variant skills societal costs tic related transmission process

项目摘要

Project Summary In this study we seek to understand how rare genetic variation in all protein coding genes (the exome) influences the risk of developing obsessive-compulsive disorder (OCD). OCD is of major public health importance owing to its profound personal and societal costs. Little is known for certain about its etiology, and treatment, detection and prevention strategies are not optimal or directed by knowledge of pathophysiology. In other psychiatric disorders (e.g., autism, intellectual disability, schizophrenia, ADHD), whole exome sequencing (WES) in large numbers of subjects has begun to deliver fundamental knowledge about genetic architecture, identify specific loci for biological follow-up and localize pathways altered in disease. We intend to realize these same advances for OCD by markedly increasing the worldwide number of OCD subjects with WES data, in a first step toward elucidating the fundamental biology of this condition. Three overlapping areas will be investigated in this project. First, we will produce WES data from 5,100 OCD subjects and 3,000 ancestry-matched controls, all from Sweden and Norway. Sequencing individuals from these countries provides the substantial advantage of knowing about co-morbid conditions. We will call rare genetic variation from the sequencing data. Second, we will combine these new data with existing WES data for ~1,400 OCD cases and ~8,000 controls. This will increase power to identify OCD risk genes, which we will do using a combination of existing and novel analytical methods. Third, we will further refine our understanding of the genetic architecture of OCD, focusing on the relationship of OCD risk to risk for other neurodevelopmental disorders, including tic disorders, autism, ADHD, schizophrenia and bipolar disorder. Combining WES data from multiple large studies will enhance power to identify shared loci and begin to identify loci with greater specificity for OCD. Overall, we believe this study will improve our understanding of genetic risk factors for OCD, with a view towards improving clinical outcomes and reducing chronicity and societal costs.

项目总结